Krah DL - Search Results

1

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults.

Krah DL, Cho I, Schofield T, Ellis RW. Krah DL, et al. Vaccine. 1997 Jan;15(1):61-4. doi: 10.1016/s0264-410x(96)00107-7. Vaccine. 1997. PMID: 9041667

2

Antibody assays suitable for assessing immune responses to live varicella vaccine.

Provost PJ, Krah DL, Kuter BJ, Morton DH, Schofield TL, Wasmuth EH, White CJ, Miller WJ, Ellis RW. Provost PJ, et al. Among authors: krah dl. Vaccine. 1991 Feb;9(2):111-6. doi: 10.1016/0264-410x(91)90266-9. Vaccine. 1991. PMID: 1647574

3

Combined use of complement and anti-immunoglobulin in an enhanced neutralization assay for antibodies to varicella-zoster virus.

Krah DL, Provost PJ, Ellis RW. Krah DL, et al. J Virol Methods. 1995 Jun;53(2-3):176-87. doi: 10.1016/0166-0934(95)00013-k. J Virol Methods. 1995. PMID: 7673386

4

Enhancement of varicella-zoster virus plaquing efficiency with an agarose overlay medium.

Krah DL, Schofield TL, Provost PJ. Krah DL, et al. J Virol Methods. 1990 Mar;27(3):319-25. doi: 10.1016/0166-0934(90)90100-t. J Virol Methods. 1990. PMID: 2157731

5

Assays for antibodies to varicella-zoster virus.

Krah DL. Krah DL. Infect Dis Clin North Am. 1996 Sep;10(3):507-27. doi: 10.1016/s0891-5520(05)70311-1. Infect Dis Clin North Am. 1996. PMID: 8856350 Review.

6

Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response.

White CJ, Kuter BJ, Ngai A, Hildebrand CS, Isganitis KL, Patterson CM, Capra A, Miller WJ, Krah DL, Provost PJ, et al. White CJ, et al. Among authors: krah dl. Pediatr Infect Dis J. 1992 Jan;11(1):19-23. doi: 10.1097/00006454-199201000-00006. Pediatr Infect Dis J. 1992. PMID: 1312704

7

WC3 reassortant vaccines in children.

Clark HF, Offit PA, Ellis RW, Krah D, Shaw AR, Eiden JJ, Pichichero M, Treanor JJ. Clark HF, et al. Arch Virol Suppl. 1996;12:187-98. doi: 10.1007/978-3-7091-6553-9_20. Arch Virol Suppl. 1996. PMID: 9015115 Review.

8

A simple antigen-reduction assay for the measurement of neutralizing antibodies to hepatitis A virus.

Krah DL, Amin RD, Nalin DR, Provost PJ. Krah DL, et al. J Infect Dis. 1991 Mar;163(3):634-7. doi: 10.1093/infdis/163.3.634. J Infect Dis. 1991. PMID: 1847404

9

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants.

Clark HF, Offit PA, Ellis RW, Eiden JJ, Krah D, Shaw AR, Pichichero M, Treanor JJ, Borian FE, Bell LM, Plotkin SA. Clark HF, et al. J Infect Dis. 1996 Sep;174 Suppl 1:S73-80. doi: 10.1093/infdis/174.supplement_1.s73. J Infect Dis. 1996. PMID: 8752294 Review.

10

Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.

Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P. Clark HF, et al. Among authors: krah dl. J Pediatr. 2004 Feb;144(2):184-90. doi: 10.1016/j.jpeds.2003.10.054. J Pediatr. 2004. PMID: 14760258 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters